{"DataElement":{"publicId":"11060758","version":"1","preferredName":"Disease Response Domain Non-Target Lesion Identification Overall Response Status","preferredDefinition":"The text term that represents the status of Non-Target Lesion Identification Overall Response.","longName":"DR_NTLOR_ST","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6941733","version":"1","preferredName":"Disease Response Domain Non-Target Lesion Identification Overall Response","preferredDefinition":"A domain for disease response evaluations._The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention._An assessment of the overall response of the disease to the therapy.","longName":"6608777v1.0:6941731v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6941731","version":"1","preferredName":"Non-Target Lesion Identification Overall Response","preferredDefinition":"The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention.:An assessment of the overall response of the disease to the therapy.","longName":"C94521:C96613","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Target Lesion Identification","conceptCode":"C94521","definition":"The identification of a lesion that is not considered a target lesion but may be affected by the therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Overall Response","conceptCode":"C96613","definition":"An assessment of the overall response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92C1C9BF-423E-4830-E053-F662850AE689","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-17","modifiedBy":"ONEDATA","dateModified":"2019-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"92C1C9BF-424F-4830-E053-F662850AE689","latestVersionIndicator":"Yes","beginDate":"2019-09-17","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-17","modifiedBy":"COOPERM","dateModified":"2020-06-04","changeDescription":"Created for CDISC aligned NCI CRF standards task. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6345652","version":"2","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._A condition or state at a particular time.","longName":"6345652v2.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unable to Assess (UA)","valueDescription":"Cannot Be Assessed","ValueMeaning":{"publicId":"2897789","version":"1","preferredName":"Cannot Be Assessed","longName":"2897789","preferredDefinition":"Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B943018-A5FF-1429-E040-BB89AD4312C2","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA719C1D-AAC3-472A-E053-4EBD850A227D","beginDate":"2021-02-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Incomplete Response/Stable Disease (IR/SD)","valueDescription":"Incomplete Response/Stable Disease","ValueMeaning":{"publicId":"6345656","version":"1","preferredName":"Incomplete Response/Stable Disease","longName":"6345656","preferredDefinition":"Persistence of one or more non-target lesions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Incomplete Response/Stable Disease","conceptCode":"C150562","definition":"Persistence of one or more non-target lesions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"701E7275-4100-4DC3-E053-F662850AADEB","latestVersionIndicator":"Yes","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA715F78-57EF-2C89-E053-4EBD850AB719","beginDate":"2018-07-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Complete Response (CR)","valueDescription":"Complete Response","ValueMeaning":{"publicId":"2570187","version":"1","preferredName":"Complete Response","longName":"2570187","preferredDefinition":"The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DF38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"KUMMEROA","dateModified":"2023-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA715F78-57F9-2C89-E053-4EBD850AB719","beginDate":"2005-05-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Progressive Disease (PD)","valueDescription":"Progressive Disease","ValueMeaning":{"publicId":"2559908","version":"1","preferredName":"Progressive Disease","longName":"2559908","preferredDefinition":"Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B711-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"HARTLEYG","dateModified":"2014-10-10","changeDescription":"Manually Curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA715F78-5803-2C89-E053-4EBD850AB719","beginDate":"2005-05-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Partial Response (PR)","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2559721","version":"1","preferredName":"Partial Response","longName":"2559721","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response","conceptCode":"C18212","definition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B656-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA715F78-580D-2C89-E053-4EBD850AB719","beginDate":"2005-05-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Stable Disease (SD)","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BA715F78-5817-2C89-E053-4EBD850AB719","beginDate":"2005-05-11","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"ONEDATA","dateModified":"2021-02-03","deletedIndicator":"No"},{"value":"Non-CR/Non-PD","valueDescription":null,"ValueMeaning":{"publicId":"5946383","version":"1","preferredName":"Non Complete Response/Non Progressive Disease","longName":"5946383v1.00","preferredDefinition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non Complete Response/Non Progressive Disease","conceptCode":"C96700","definition":"Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"58007ED1-215D-70C3-E053-F662850A7199","latestVersionIndicator":"Yes","beginDate":"2017-08-30","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-30","modifiedBy":"MMADDINENI","dateModified":"2022-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5E8D8A2-8F83-241C-E053-731AD00A9032","beginDate":"2022-08-10","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-08-10","modifiedBy":"MMADDINENI","dateModified":"2022-08-10","deletedIndicator":"No"},{"value":"Not present","valueDescription":null,"ValueMeaning":{"publicId":"3204360","version":"1","preferredName":"Absent","longName":"3204360","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E9F26F2-9C11-947B-E040-BB89AD434D7C","latestVersionIndicator":"Yes","beginDate":"2011-03-16","endDate":null,"createdBy":"LUY","dateCreated":"2011-03-16","modifiedBy":"CLOHNES","dateModified":"2023-11-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/30/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8BA2D84-F641-7E97-E053-731AD00A347D","beginDate":"2022-09-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-15","modifiedBy":"KUMMEROA","dateModified":"2022-09-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6612626","version":"1","preferredName":"Disease Response Status","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.:A condition or state at a particular time.","longName":"C50995:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F861447-6ADE-182F-E053-F662850A17F5","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA715F78-57CD-2C89-E053-4EBD850AB719","latestVersionIndicator":"Yes","beginDate":"2021-02-03","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-02-03","modifiedBy":"KUMMEROA","dateModified":"2022-09-15","changeDescription":"Note: Fixed the concepts for Unable to Assess & updated primary concepts - LS 2/3/21","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RS_RSORRES_NTRGRESP","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Non-Target Lesions overall response","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5E921F0-5AB7-2CCA-E053-731AD00A11CD","latestVersionIndicator":"Yes","beginDate":"2022-08-10","endDate":null,"createdBy":"MMADDINENI","dateCreated":"2022-08-10","modifiedBy":"MMADDINENI","dateModified":"2022-08-11","changeDescription":null,"administrativeNotes":"08/10/2022- COG curation request- CADSR0001333 - MM","unresolvedIssues":null,"deletedIndicator":"No"}}